Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8+ T cell responses

Publication date: Available online 10 April 2020Source: Journal of Pharmacological SciencesAuthor(s): Momo Kamei, Kazuhiko Matsuo, Haruka Imanishi, Yuta Hara, Ying-Shu Quen, Fumio Kamiyama, Naoki Oiso, Akira Kawada, Naoki Okada, Takashi Nakayama
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research